$VTIX

Virtuix launches Omni One for Quest, expands to Meta ecosystem

Virtuix Inc. (VTIX) launched Omni One for Quest, an omni-directional treadmill for Meta Quest headsets. The product, priced at $2,595 in the U.S., is compatible with Quest 2 and 3 and launches with several popular games. The company aims to expand its market reach and positions the product as a fitness solution for gamers.

Original reporting
Published Aug 30, 2026, 3:27 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 31, 2026, 7:13 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Virtuix launches Omni One for Quest, expands to Meta ecosystem — source image
Decision brief

The 30-second read

$VTIXNeutralLow
01

Why it matters

The launch expands Virtuix's addressable market to millions of Quest users, positioning the company in the fast‑growing XR space.

02

Market read

New product launch may modestly affect VTIX stock; broader XR market sees continued growth.

03

What to watch

Potential competition from other treadmill makers and Meta's own hardware roadmap.

Relevance 6/10Novelty 7/10Timing: post‑launch availability June 23, 2026

Background

Virtuix's Omni One for Quest integrates full‑body movement into Meta Quest games, priced at $2,595 in the US.

Company-level read

Ticker impact

$VTIXNeutralMedium confidence
Context

Virtuix Inc. announced the launch of Omni One for Quest, a new omni‑directional treadmill for Meta Quest headsets, expanding its addressable market.

Expected impact

Potential modest upside if early sales exceed expectations; downside risk if demand lags.

Evidence & confidence

Launch provides a fresh revenue stream but limited scale and high price point suggest limited immediate price move.

Market effects

Highlights growing ecosystem partnerships between XR hardware makers and Meta's Quest platform.

US‑based VR hardware market may see incremental demand.

Limited to niche XR segment; broader market impact minimal.

Counterpoint

High price and niche appeal could limit adoption, weighing on VTIX.

Key entities

  • Virtuix Inc.

    Developer of omni‑directional treadmill technology.

  • Meta Platforms

    Owner of the Quest VR ecosystem.

Related articles

$VTIXMed

Quarterly revenue beat analyst expectations by more than 50% at Virtuix

Virtuix (VTIX) reported quarterly revenue exceeding analyst expectations by over 50%, driven by strong consumer demand for its Omni One platform. The company will present at the H.C. Wainwright conference, highlighting expansions into defense, robotics, healthcare, and enterprise markets, including partnerships with Tesla and the U.S. Marine Corps. VTIX stock declined 9.52% on the news.

$VTIXMed

Research firm sees 644% potential upside for Virtuix; orders rose 72% after Meta partnership

Emerging Growth Research reaffirmed its Buy-Emerging rating and $9.00 price target for Virtuix (VTIX), implying 644% upside. Q1 2027 revenue was $0.8M, down 26% YoY but above estimates, driven by a 72% rise in new orders post-Meta partnership. Gross margin expanded to 30%, and EPS improved sequentially to $(0.22). The firm projects 19% and 275% revenue growth for fiscal 2027 and 2028, respectively, but notes execution and financing risks.

$VTIXMed

Virtuix Holdings Inc. (VTIX): Results of Operations and Financial Condition

Virtuix Holdings Inc. (VTIX) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Virtuix Reports First Quarter Fiscal Year 2027 Results as Omni One Orders Increase 150% Following Meta Launch Orders Increased 72% Year-over-Year and Approximately 150% Since the Launch of Omni One for Quest as Meta Launch Drives Accelerating Consumer Demand Gross Pr

$VTIXHigh

Virtuix Q1 sales $767K, EPS ($0.22) beat estimates

Virtuix (VTIX) reported Q1 FY2027 net sales of $767K, beating estimates, with a net loss per share of ($0.22). Gross profit rose 29% to $227K, driven by higher selling prices. Operating expenses increased 86% to $4.1M. The company secured its first Omni One Enterprise sale to Tesla. Cash reserves stood at $7.4M. The earnings release and conference call were rescheduled to August 19-20, 2026, due to a new audit firm's review.

$VTIXMed

Virtuix Reports 72% Year-over-Year Order Growth, Margin Expansion, and New Defense, Enterprise, and Healthcare Wins in Fiscal Q1 2027

Virtuix reported a 72% year-over-year increase in orders and a 29% rise in gross profit for Q1 2027. Gross margin expanded to 30% from 17%. The company secured new defense, enterprise, and healthcare contracts, including deals with Tesla, NASA, and the U.S. Marine Corps. Net sales were $0.8 million, down 26% year-over-year, but orders surged.